DEFA14A: Protagenic Therapeutics Corrects Record Date and Share Count in Proxy Statement Supplement
Proxy Statement Supplement
Protagenic Therapeutics issues a supplement to its proxy statement to correct an error in the record date and the number of outstanding shares.
Summary
- Protagenic Therapeutics has filed a supplement to its proxy statement for the 2024 Annual Meeting of Shareholders.
- The supplement corrects an error in the Notice of Virtual Annual Meeting of Stockholders regarding the record date, which is December 30, 2024, not January 3, 2025.
- The supplement also corrects the number of outstanding shares of common stock as of the record date, which is 7,241,443, not 7,143,318.
- The Annual Meeting will be held on February 21, 2025, at 10:00 a.m. Eastern Time online.
- The supplement does not change the proposals to be acted upon at the Annual Meeting.
- Shareholders who have already voted do not need to take any action unless they wish to change or revoke their vote.
- Shareholders who have not yet voted are encouraged to do so as soon as possible.
Sentiment
Score: 7
Explanation: The document is a neutral correction of previously released information, indicating a focus on accuracy and compliance.
Positives
- The company is proactively correcting errors in its proxy statement to ensure accurate information for shareholders.
Negatives
- The proxy statement contained errors regarding the record date and the number of outstanding shares.
Risks
- Inaccurate information in proxy materials could potentially lead to shareholder confusion or distrust.
Industry Context
This announcement is a standard corporate communication related to shareholder meetings and proxy voting, common among publicly traded companies.
Stakeholder Impact
- Shareholders are directly impacted by the corrected information, ensuring they have accurate data for voting decisions.
Next Steps
- Shareholders should review the corrected information and vote their shares if they have not already done so.
Key Dates
| Date | Description |
|---|---|
| January 3, 2025 | Protagenic Therapeutics filed and commenced distribution of the Notice of Annual Meeting and Proxy Statement. |
| January 6, 2025 | Date of the supplement to the proxy statement. |
| February 21, 2025 | Date of the 2024 Annual Meeting of Shareholders. |
Keywords
Proxy Statement, Annual Meeting, Record Date, Shareholders, Protagenic Therapeutics, Shares Outstanding, Correction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.